Toi M - Search Results

1

Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer.

Kuroi K, Toi M, Tsuda H, Kurosumi M, Akiyama F. Kuroi K, et al. Among authors: toi m. Biomed Pharmacother. 2005 Oct;59 Suppl 2:S387-92. doi: 10.1016/s0753-3322(05)80085-x. Biomed Pharmacother. 2005. PMID: 16507416 Review.

2

Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.

Osaki A, Toi M, Yamada H, Kawami H, Kuroi K, Toge T. Osaki A, et al. Among authors: toi m. Am J Surg. 1992 Oct;164(4):323-6. doi: 10.1016/s0002-9610(05)80897-9. Am J Surg. 1992. PMID: 1357997

3

[Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients].

Osaki A, Toi M, Yamada H, Kawami H, Kuroi K, Toge T. Osaki A, et al. Among authors: toi m. Gan To Kagaku Ryoho. 1991 Jun;18(7):1181-5. Gan To Kagaku Ryoho. 1991. PMID: 1675844 Japanese.

4

Primary squamous cell carcinoma of the breast after cured Hodgkin's disease.

Kuroi K, Osaki A, Yamada H, Toi M, Toge T, Takimoto Y, Kuramoto A, Arihiro K, Inai K. Kuroi K, et al. Among authors: toi m. Surg Today. 1993;23(1):81-4. doi: 10.1007/BF00309006. Surg Today. 1993. PMID: 8461611

5

[Breast cancer angiogenesis].

Toi M, Tominaga T. Toi M, et al. Gan To Kagaku Ryoho. 1996 May;23(6):659-66. Gan To Kagaku Ryoho. 1996. PMID: 8645013 Review. Japanese.

6

Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.

Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, Iwanari H, Tominaga T. Toi M, et al. Clin Cancer Res. 1998 Mar;4(3):659-64. Clin Cancer Res. 1998. PMID: 9533534

7

[Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline].

Nagai S, Toi M, Kuroi K, Hayashi K, Tominaga T. Nagai S, et al. Among authors: toi m. Gan To Kagaku Ryoho. 1999 Nov;26(13):2037-42. Gan To Kagaku Ryoho. 1999. PMID: 10584568 Clinical Trial. Japanese.

8

[Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors].

Toi M, Matsumoto G, Bando H, Kuroi K. Toi M, et al. Gan To Kagaku Ryoho. 2000 Jul;27(8):1212-6. Gan To Kagaku Ryoho. 2000. PMID: 10945019 Japanese.

9

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K. Ueno T, et al. Among authors: toi m. Clin Cancer Res. 2000 Aug;6(8):3282-9. Clin Cancer Res. 2000. PMID: 10955814

10

[Angiogenesis as a prognostic factor of breast cancers].

Kuroi K, Toi M. Kuroi K, et al. Among authors: toi m. Nihon Rinsho. 2000 Apr;58 Suppl:435-41. Nihon Rinsho. 2000. PMID: 11026030 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

786 results

Search Page

Filters